Esther Lee - Dec 31, 2021 Form 4 Insider Report for CLOROX CO /DE/ (CLX)

Role
Director
Signature
By Cheryl Brice, Attorney-in-Fact for
Stock symbol
CLX
Transactions as of
Dec 31, 2021
Transactions value $
$0
Form type
4
Date filed
1/4/2022, 03:18 PM
Previous filing
Jun 16, 2021
Next filing
Jan 4, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLX Deferred Stock Units +Grant/Award $0 +49 +0.6% $0.00 8,201 Feb 12, 2021 Common Stock 49 Direct F1, F2, F3
transaction CLX Deferred Stock Units +Grant/Award $0 +50 +0.61% $0.00 8,251 May 7, 2021 Common Stock 50 Direct F1, F2, F3
transaction CLX Deferred Stock Units +Grant/Award $0 +57 +0.69% $0.00 8,307 Aug 13, 2021 Common Stock 57 Direct F1, F2, F3
transaction CLX Deferred Stock Units +Grant/Award $0 +58 +0.7% $0.00 8,366 Nov 10, 2021 Common Stock 58 Direct F1, F2, F3
transaction CLX Deferred Stock Units +Grant/Award $0 +919 +10.98% $0.00 9,284 Dec 31, 2021 Common Stock 919 Direct F1, F3, F4

Explanation of Responses:

Id Content
F1 1-for-1
F2 Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan.
F3 The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director.
F4 Annual award of Deferred Stock Units pursuant to the 2005 Stock Incentive Plan.